留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

Toll-like receptors 2 polymorphism is associated with psoriasis: A case-control study in the northern Chinese population

Siyu Hao Yu Zhang Anqi Yin Ying Lyu Nannan Tong Jiangtian Tian Yuzhen Li

Siyu Hao, Yu Zhang, Anqi Yin, Ying Lyu, Nannan Tong, Jiangtian Tian, Yuzhen Li. Toll-like receptors 2 polymorphism is associated with psoriasis: A case-control study in the northern Chinese population[J]. Frigid Zone Medicine, 2024, 4(2): 96-101. doi: 10.1515/fzm-2024-0010
Citation: Siyu Hao, Yu Zhang, Anqi Yin, Ying Lyu, Nannan Tong, Jiangtian Tian, Yuzhen Li. Toll-like receptors 2 polymorphism is associated with psoriasis: A case-control study in the northern Chinese population[J]. Frigid Zone Medicine, 2024, 4(2): 96-101. doi: 10.1515/fzm-2024-0010

Toll-like receptors 2 polymorphism is associated with psoriasis: A case-control study in the northern Chinese population

doi: 10.1515/fzm-2024-0010
Funds: 

grants from the National Natural Science Foundation of China 82304000

More Information
  • Figure  1.  Linkage disequilibrium analyses

    Table  1.   Sequence of primers

    Primer position Primer sequence (5'-3')
    s11938228
      Forward primer GGGGCAAGAATAACCAAGACACA
      Reverse primer GACATGCCCATATAGGGGTAGATCTTG
    rs4696480
      Forward primer GGTTCTGGAGTCTGGGAAGTCCA
      Reverse primer ACTGCGAGCTGAGAGGTGGAAC
    rs3804099
      Forward primer TGCAAATCCTGAGAGTGGGAAAT
      Reverse primer TCCAAACATTCCACGGAACTTG
    rs5743699
      Forward primer AGGATGCCTGGCCCTCTCTACA
      Reverse primer TGTCTTGGGAATGCAGCCTGTT
    下载: 导出CSV

    Table  2.   iMLDR probe sequences

    SNP allele Primer sequence (5'-3') LDR product
    s11938228_modify TCTATCCCTATACCAGCAACACACTATATTAAATTTTTTTTTTT 63.21
    s11938228_C TTCCGCGTTCGGACTGATATTCAGTGCTATTCTGATCCAATGTTCATGTG 67.77
    s11938228_A TACGGTTATTCGGGCTCCTGTTCAGTGCTATTCTGATCCAATGTTCATGTT 66.56
    rs4696480_modify GAGGGTCATCTGGCTACATTATAACATGTTTTTTTTTT 63.95
    rs4696480_A TCTCTCGGGTCAATTCGTCCTTCAAGATTGAAGGGCTGCATCTCGA 68.65
    rs4696480_T TGTTCGTGGGCCGGATTAGTCAAGATTGAAGGGCTGCATCTCGT 67.70
    rs3804099_modify GTAAGTCATCTGATCCTTCATATGAAGCATTTTTTTTT 63.00
    rs3804099_C TTCCGCGTTCGGACTGATATGAGCCAAAAAGTTTGAAGTCAATTCAGTAC 66.86
    rs3804099_T TACGGTTATTCGGGCTCCTGTGAGCCAAAAAGTTTGAAGTCAATTCAGCAT 66.40
    rs5743699_modify TGAGCAAAGTCTCTCCGGTTTTTTTTTTTTTT 63.53
    rs5743699_C TCTCTCGGGTCAATTCGTCCTTTCTTACTGATATCAATGTTAGTCAAGTTTTTCACAG 64.81
    rs5743699_T TGTTCGTGGGCCGGATTAGT TCTTACTGATATCAATGTTAGTCAAGTTTTTCACAA 65.02
    下载: 导出CSV

    Table  3.   Demographic characteristics of the studied population

    Characteristic Cases, (N = 270) Controls, (N = 247) P
    Gender, N (%)
      Male 166 (61.5) 142 (57.5) 0.3706
      Female 104 (38.5) 105 (42.5)
    Age, years 38.17 ± 9.90 37.94 ± 9.70 0.7890
    PASI, N (%)
      ≤ 10 223 (82.6) - -
      > 10 47 (17.4) - -
    Age at onset, N (%)
      ≤ 40 years 219 (81.1) - -
      > 40 years 51 (18.9) - -
    Family history, N (%)
      Yes 102 (37.8) - -
      No 168 (62.2) - -
    Data were presented as N(%).
    下载: 导出CSV

    Table  4.   Allele and genotype frequencies of TLR2 SNPs in the case and control groups

    SNP Model Controls Cases OR (95% CI) P P* OR (95% CI) P#
    rs11938228 Codominant C/C 56 (22.7) 91 (33.7) 1.00 0.00180 0.0072 1.00 0.0016
    C/A 124 (50.2) 135 (50.0) 0.67 (0.44-1.01) 0.66 (0.43-1.00)
    A/A 67 (27.1) 44 (16.3) 0.40 (0.24-0.67) 0.40 (0.24-0.66)
    C 236 (47.8) 317 (58.7) 1.00 0.00054 0.0022
    A 258 (52.2) 223 (41.3) 0.64 (0.50-0.82)
    Dominant C/C 56 (22.7) 91 (33.7) 1.00 0.00530 0.0212 1.00 0.0041
    C/A-A/A 191 (77.3) 179 (66.3) 0.58 (0.39-0.85) 0.57 (0.38-0.84)
    Recessive C/C-C/A 180 (72.9) 226 (83.7) 1.00 0.00270 0.0108 1.00 0.0027
    A/A 67 (27.1) 44 (16.3) 0.52 (0.34-0.80) 0.52 (0.34-0.80)
    Overdominant C/C-A/A 123 (49.8) 135 (50.0) 1.00 0.96000 1.00 1.00 0.9100
    C/A 124 (50.2) 135 (50.0) 0.99 (0.70-1.40) 0.98 (0.69-1.39)
    rs4696480 Codominant A/A 57 (23.1) 87 (32.2) 1.00 0.01300 0.052 1.00 0.0120
    A/T 125 (50.6) 136 (50.4) 0.71 (0.47-1.08) 0.70 (0.46-1.06)
    T/T 65 (26.3) 47 (17.4) 0.47 (0.29-0.78) 0.47 (0.28-0.78)
    A 239 (48.4) 310 (57.4) 1.00 0.00400 0.016
    T 255 (51.6) 230 (42.6) 0.70(0.54-0.89)
    Dominant A/A 57 (23.1) 87 (32.2) 1.00 0.02000 0.08 1.00 0.0170
    A/T-T/T 190 (76.9) 183 (67.8) 0.63 (0.43-0.93) 0.62 (0.42-0.92)
    Recessive A/A-A/T 182 (73.7) 223 (82.6) 1.00 0.01400 0.056 1.00 0.0150
    T/T 65 (26.3) 47 (17.4) 0.59 (0.39-0.90) 0.59 (0.39-0.91)
    Overdominant A/A-T/T 122 (49.4) 134 (49.6) 1.00 0.96000 1.00 1.00 0.9000
    A/T 125 (50.6) 136 (50.4) 0.99 (0.70-1.40) 0.98 (0.69-1.38)
    rs3804099 Codominant T/T 123 (49.8) 121 (44.8) 1.00 0.52000 1.00 1.00 0.5300
    C/T 106 (42.9) 127 (47.0) 1.22 (0.85-1.75) 1.21 (0.85-1.74)
    C/C 18 (7.3) 22 (8.2) 1.24 (0.63-2.43) 1.26 (0.64-2.46)
    T 352 (71.3) 369 (68.3) 1.00 0.30700 1.00
    C 142 (28.7) 171 (31.7) 1.15 (0.88-1.50)
    Dominant T/T 123 (49.8) 121 (44.8) 1.00 0.26000 1.00 1.00 0.2600
    C/T-C/C 124 (50.2) 149 (55.2) 1.22 (0.86-1.73) 1.22 (0.86-1.72)
    Recessive T/T-C/T 229 (92.7) 248 (91.8) 1.00 0.71000 1.00 1.00 0.6800
    C/C 18 (7.3) 22 (8.2) 1.13 (0.59-2.16) 1.15 (0.60-2.19)
    Overdominant T/T-C/C 141 (57.1) 143 (53.0) 1.00 0.35000 1.00 1.00 0.3600
    rs5743699 C/T 106 (42.9) 127 (47.0) 1.18 (0.83-1.67) 1.18 (0.83-1.67)
    C/C 245 (99.2) 268 (99.3) 1.00 0.93000 1.00 1.00 0.8600
    C/T 2 (0.8) 2 (0.7) 0.91 (0.13-6.54) 0.84 (0.12-6.05)
    C 492 (99.6) 538 (99.6) 1.00 0.93000 1.00
    T 2 (0.4) 2 (0.4) 0.91 (0.13-6.54)
    Data were presented as N(%). P: model-based statistical P value, P*: P value adjusted Bonferroni correction, P#: P value adjusted by age and sex; OR: odds ratio; 95% CI: 95% confidence interval.
    下载: 导出CSV

    Table  5.   Haplotype association with psoriasis

    rs11938228 rs4696480 rs3804099 rs5743699 Total Frequency in control Frequency in cases OR (95% CI) P P* OR (95% CI) P#
    1 A T T C 0.44 0.48 0.40 0.713 (0.557-0.912) 0.007 0.113 0.705 (0.551-0.902) 0.005
    2 C A C C 0.28 0.25 0.30 1.262 (0.960-1.661) 0.095 1.000 1.236 (0.941-1.623) 0.126
    3 C A T C 0.24 0.21 0.26 1.299 (0.974-1.732) 0.075 1.000 1.328 (0.994-1.775) 0.054
    4 A T C C 0.01 0.02 0.01 0.248 (0.067-0.916) 0.024 0.383 0.225 (0.047-1.068) 0.04
    5 C T T C 0.01 0.01 0.01 2.512 (0.623-10.133) 0.180 1.000 2.461 (0.649-9.329) 0.171
    6 A A T C 0.01 0.01 0.01 1.289 (0.334-4.975) 0.711 1.000 1.144 (0.305-4.287) 0.84
    7 C T C C 0.01 0 0.01 1.836 (0.382-8.831) 0.441 1.000 1.835 (0.334-10.067) 0.477
    9 A T T T 0 0 0 0.027 (0.001-0.507) 0.267 1.000 - -
    P*: P value after Bonferroni correction; P#: the OR and P values were adjusted for age and sex.
    下载: 导出CSV

    Table  6.   Analysis of linkage disequilibrium based on evaluation of D' in patients

    rs11938228 rs4696480 rs3804099 rs5743699
    rs11938228 - 0.948 0.869 0.961
    rs4696480 - - 0.852 0.956
    rs3804099 - - - 0.449
    rs5743699 - - - -
    下载: 导出CSV

    Table  7.   Analysis of linkage disequilibrium based on R2 statistics in patients

    rs11938228 rs4696480 rs3804099 rs5743699
    rs11938228 - 0.885 0.285 0.004
    rs4696480 - - 0.278 0.004
    rs3804099 - - - 0
    rs5743699 - - - -
    下载: 导出CSV
  • [1] Griffiths C E, Barker J N. Pathogenesis and clinical features of Psoriasis. Lancet, 2007; 370(9583): 263-271. doi: 10.1016/S0140-6736(07)61128-3
    [2] Yin X, Low H Q, Wang L, et al. Genome-wide meta-analysis identifies multiple novel associations and ethnic heterogeneity of psoriasis susceptibility. Nat Commun, 2015; 6(1): 6916. doi: 10.1038/ncomms7916
    [3] Grän F, Kerstan A, Serfling E, et al. Current developments in the immunology of psoriasis. Yale J Biol Med, 2020; 93(1): 97-110.
    [4] Conrad C, Gilliet M. Psoriasis: from pathogenesis to targeted therapies. Clin Rev Allergy Immunol, 2018; 54(1): 102-113. doi: 10.1007/s12016-018-8668-1
    [5] Miller L S. Toll-like receptors in skin. Adv Dermatol, 2008, 24: 71-87. doi: 10.1016/j.yadr.2008.09.004
    [6] Chen J-Q, Szodoray P, Zeher M. Toll-Like receptor pathways in autoimmune diseases. Yale J Biol Med, 2016; 50(1): 1-17. doi: 10.1007/s12016-015-8473-z
    [7] Ermertcan A T, Öztürk F, Gündüz K. Toll-like receptors and skin: TLRs and skin. Journal of the J Eur Acad Dermatol Venereol, 2011; 25(9): 997-1006. doi: 10.1111/j.1468-3083.2011.04049.x
    [8] Marks K E, Cho K, Stickling C, et al. Toll-like receptor 2 in autoimmune inflammation. Immune Network, 2021; 21(3): e18. doi: 10.4110/in.2021.21.e18
    [9] Garcia-Rodriguez S, Arias-Santiago S, Perandrés-López R, et al. Increased gene expression of Toll-like receptor 4 on peripheral blood mononuclear cells in patients with psoriasis: TLR4 up-regulation in psoriasis PBMC. J Eur Acad Dermatol Venereol, 2013; 27(2): 242-250. doi: 10.1111/j.1468-3083.2011.04372.x
    [10] Carrasco S, Neves F S, Fonseca M H, et al. Toll-like Receptor (TLR) 2 is upregulated on peripheral blood monocytes of patients with psoriatic arthritis: a role for a gram-positive inflammatory trigger? Clin Exp Rheumatol, 2011; 29(6): 958-962.
    [11] Genetic Analysis of Psoriasis Consortium & the Wellcome Trust Case Control Consortium 2. A Genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Gene, 2010; 42(11): 985-990. doi: 10.1038/ng.694
    [12] Stuart P E, Nair R P, Ellinghaus E, et al. Genome-wide association analysis identifies three psoriasis susceptibility Loci. Nat Gene, 2010, 42(11): 1000-1004. doi: 10.1038/ng.693
    [13] Sun L D, Cheng H, Wang Z X, et al. Association analyses identify six new psoriasis susceptibility loci in the Chinese population. Nate Gene, 2010; 42(11): 1005-1009. doi: 10.1038/ng.690
    [14] Collaborative Association Study of Psoriasis (CASP), Genetic Analysis of Psoriasis Consortium, Psoriasis Association Genetics Extension, et al. Identification of 15 new psoriasis susceptibility loci highlights the role of innate Immunity. Nat Gene, 2012; 44(12): 1341-1348. doi: 10.1038/ng.2467
    [15] Shi G, Wang T, Li S, et al. TLR2 and TLR4 polymorphisms in Southern Chinese psoriasis vulgaris patients. J Dermatol Sci, 2016; 83(2): 145-147. doi: 10.1016/j.jdermsci.2016.04.014
    [16] Sabah-Özcan S, Gürel G. The polymorphism rs4696480 in the TLR2 gene is associated with psoriasis patients in the Turkish Population. Immunol Let, 2019; 211: 28-32. doi: 10.1016/j.imlet.2019.05.008
    [17] Gowin E, Świątek-Kościelna B, Kałużna E, et al. Analysis of TLR2, TLR4, and TLR9 single nucleotide polymorphisms in children with bacterial meningitis and their healthy family Members. Int J Infect Dis, 2017; 60: 23-28. doi: 10.1016/j.ijid.2017.04.024
    [18] Zhou B, Liang S, Shang S, et al. Association of TLR2 and TLR9 gene polymorphisms with atopic dermatitis: a systematic review and meta-analysis with trial sequential Analysis. Immunol Med, 2023; 46(1): 32-44. doi: 10.1080/25785826.2022.2132683
    [19] Loft N D, Skov L, Iversen L, et al. Associations between functional polymorphisms and response to biological treatment in Danish patients with Psoriasis. Pharmacogenomics J, 2018; 18(3): 494-500. doi: 10.1038/tpj.2017.31
    [20] Lorenz E, Mira J P, Cornish K L, et al. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect Immun, 2000; 68(11): 6398-6401. doi: 10.1128/IAI.68.11.6398-6401.2000
    [21] Zhou B, Liang S, Shang S, et al. Association of TLR2 and TLR9 gene polymorphisms with atopic dermatitis: a systematic review and meta-analysis with trial sequential Analysis. Immunol Med, 2022: 1-13.
    [22] Potaczek D P, Przytulska-Szczerbik A, Bazan-Socha S, et al. Interaction between functional polymorphisms in FCER1A and TLR2 and the severity of atopic Dermatitis. Human Immunol, 2020; 81(12): 709-713. doi: 10.1016/j.humimm.2020.08.002
    [23] Elloumi N, Tahri S, Fakhfakh R, et al. Role of innate immune receptors TLR4 and TLR2 polymorphisms in systemic lupus erythematosus Susceptibility. Ann Human Gene, 2022; 86(3): 137-144. doi: 10.1111/ahg.12458
    [24] Zhang Y, Wang H C, Feng C, et al. Analysis of the association of polymorphisms rs5743708 in TLR2 and rs4986790 in TLR4 with atopic dermatitis risk. Immunol Invest, 2019; 48(2): 169-180. doi: 10.1080/08820139.2018.1508228
    [25] Zhang F, Gao X D, Wu W W, et al. Polymorphisms in Toll-like receptors 2, 4 and 5 are associated with legionella pneumophila Infection. Infection, 2013; 41(5): 941-948. doi: 10.1007/s15010-013-0444-9
    [26] Shi G, Wang T, Li S, et al. TLR2 and TLR4 polymorphisms in Southern Chinese psoriasis vulgaris patients. J Dermatol Sci, 2016; 83(2): 145-147. doi: 10.1016/j.jdermsci.2016.04.014
  • 加载中
图(1) / 表(7)
计量
  • 文章访问数:  93
  • HTML全文浏览量:  52
  • PDF下载量:  5
  • 被引次数: 0
出版历程
  • 收稿日期:  2024-01-11
  • 录用日期:  2024-04-25
  • 网络出版日期:  2024-08-07

目录

    /

    返回文章
    返回